Diagnostik und Therapie unklarer Gallengangsstenosen

Abstract

Biliary stenoses represent a differential diagnostic challenge. Diagnostic methods to clarify the underlying dignity are often invasive, and provide high specificity beside insufficient sensitivity. In many cases, an accurate diagnosis is only possible over time, and therefore limits curative treatment options. This article provides an overview of the diagnostic challenges and treatment options for unclear biliary stenosis.

Gallengangsstenosen stellen eine differenzialdiagnostische Herausforderung dar. Die Diagnostik zur Klärung der Dignität ist häufig invasiv und bietet bei hoher Spezifität nur unzureichende Sensitivität. Die Diagnose lässt sich oft erst im zeitlichen Verlauf stellen, kurative Therapieoptionen sind dadurch limitiert. Dieser Beitrag bietet einen Überblick über die diagnostischen Herausforderungen und Therapiemöglichkeiten unklarer Gallengangsstenosen.

Schlüsselwörter

Gallengangsstenosen - unklare biliäre Läsionen - seltene Gallenwegserkrankungen

Key words

bile duct stenoses - unclear biliary lesions - rare biliary diseases

Publication History

Article published online:
02 March 2020

• Literatur

• 1 Altman A, Zangan S. Benign Biliary Strictures. Semin Intervent Radiol 2016; 33: 297-306 . doi: 10.1055/s-0036-1592325
• 2 Bowlus CL, Olson KA, Eric Gershwin M. Evaluation of indeterminate biliary strictures. Nat Rev Gastroenterol Hepatol 2016; 13: 28-37 . doi: 10.1038/nrgastro.2015.182
• 3 Bowlus CL, Lim JK, Lindor KD. AGA Clinical Practice Update on Surveillance for Hepatobiliary Cancers in Patients With Primary Sclerosing Cholangitis : Expert Review. Clin Gastroenterol Hepatol 2019; 1-7 . doi:10.1016/j.cgh.2019.07.011
• 4 Karlsen TH, Folseraas T, Thorburn D. et al Primary sclerosing cholangitis – a comprehensive review. J Hepatol 2017; 67: 1298-1323 . doi:10.1016/j.jhep.2017.07.022
• 5 Weismüller TJ, Trivedi PJ, Bergquist A. et al Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis. Gastroenterology 2017; 152: 1975-1984 . doi:10.1053/j.gastro.2017.02.038
• 6 Grimsrud MM, Folseraas T. Pathogenesis, diagnosis and treatment of premalignant and malignant stages of cholangiocarcinoma in primary sclerosing cholangitis. Liver Int 2019; 39: 2230-2237 . doi:10.1111/liv.14180
• 7 Ghazale A, Chari ST, Zhang L. et al Immunoglobulin G4-Associated Cholangitis: Clinical Profile and Response to Therapy. Gastroenterology 2008; 134: 706-715 . doi:10.1053/j.gastro.2007.12.009
• 8 Strassburg CP, Beckebaum S, Geier A. et al S2k Leitlinie Autoimmune Lebererkrankungen. Z Gastroenterol 2017; 55: 1135-1226 . doi:10.1055/s-0043-120199
• 9 Khan SA, Tavolari S, Brandi G. Cholangiocarcinoma: Epidemiology and risk factors. Liver Int 2019; 39: 19-31 . doi:10.1111/liv.14095
• 10 Cillo U, Fondevila C, Donadon M. et al Surgery for cholangiocarcinoma. Liver Int 2019; 39: 73-77 . doi:10.1111/liv.14089
• 11 Kushnir VM, Mullady DK, Das K. et al The Diagnostic Yield of Malignancy Comparing Cytology, FISH, and Molecular Analysis of Cell Free Cytology Brush Supernatant in Patients With Biliary Strictures Undergoing Endoscopic Retrograde Cholangiography (ERC). J Clin Gastroenterol 2019; 53: 686-692 . doi:10.1111/liv.14095
• 12 Kamisawa T, Ohara H, Kim MH. et al Role of endoscopy in the diagnosis of autoimmune pancreatitis and immunoglobulin G4-related sclerosing cholangitis. Dig Endosc 2014; 26: 627-635 . doi:10.1111/den.12289
• 13 Dawwas MF, Oppong KW, Webster GJ. Endoscopic assessment and management of biliary strictures. Frontline Gastroenterol 2015; 170-175 . doi:10.1136/flgastro-2015-100570
• 14 Voigtländer T, Lankisch TO. Endoscopic diagnosis of cholangiocarcinoma: From endoscopic retrograde cholangiography to bile proteomics. Best Pract Res Clin Gastroenterol 2015; 29: 267-275 . doi:10.1016/j.bpg.2015.02.005
• 15 Severino V, Dumonceau JM, Delhaye M. et al Extracellular Vesicles in Bile as Markers of Malignant Biliary Stenoses. Gastroenterology 2017; 153: 495-504.e8 . doi:10.1053/j.gastro.2017.04.043
• 16 Andresen K, Boberg KM, Vedeld HM. et al Four DNA methylation biomarkers in biliary brush samples accurately identify the presence of cholangiocarcinoma. Hepatology 2015; 61: 1651-1659 . doi:10.1136/flgastro-2015-100570
• 17 European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Management of cholestatic liver diseases. J Hepatol 2009; 51: 237-267 . doi:10.1016/j.jhep.2009.04.009
• 18 Aabakken L, Karlsen TH, Albert J. et al Role of endoscopy in primary sclerosing cholangitis: European Society of Gastrointestinal Endoscopy (ESGE) and European Association for the Study of the Liver (EASL) Clinical Guideline. J Hepatol 2017; 66: 1265-1281 . doi:10.1016/j.jhep.2017.02.013
• 19 Adeva J, Sangro B, Salati M. et al Medical treatment for cholangiocarcinoma. Liver Int 2019; 39: 123-142 . doi:10.1111/liv.14100
• 20 Duan F, Cui L, Bai Y. et al Comparison of efficacy and complications of endoscopic and percutaneous biliary drainage in malignant obstructive jaundice: A systematic review and meta-analysis. Cancer Imaging 2017; 17: 1-7 . doi:10.1186/s40644-017-0129-1